NeuroPace, Inc.
(NASDAQ : NPCE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.95%550.231.0%$627.91m
ABTAbbott Laboratories -0.54%108.710.8%$582.63m
DHRDanaher Corp. 1.31%258.860.7%$580.05m
MDTMedtronic Plc -0.86%89.720.6%$545.80m
ISRGIntuitive Surgical, Inc. -0.11%206.520.8%$421.78m
BSXBoston Scientific Corp. -0.15%37.711.0%$341.07m
ALGNAlign Technology, Inc. -1.12%251.276.4%$291.76m
BDXBecton, Dickinson & Co. 0.30%248.671.0%$283.98m
SYKStryker Corp. -0.77%200.471.3%$278.45m
EWEdwards Lifesciences Corp. -0.56%97.420.4%$263.16m
IDXXIDEXX Laboratories, Inc. 2.81%377.193.8%$235.51m
BAXBaxter International, Inc. -0.15%65.301.8%$205.56m
DXCMDexCom, Inc. 1.43%79.581.9%$200.22m
AAgilent Technologies, Inc. 0.42%121.071.7%$198.37m
SWAVShockwave Medical, Inc. -3.80%194.150.0%$177.34m

Company Profile

NeuroPace, Inc. develops, manufactures and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's product RNS system is designed for the treatment of medically refractory partial epilepsy includes implantable and external products. The company was founded by Robert Fischell, David Fischell, Tim Fischell, Scott Fischell, Rebecca L. Kuhn, Frank M. Fischer and Martha Morrell on November 19, 1997 and is headquartered in Mountain View, CA.